Label

How We Work

Grant

Back

Print

Pfizer Inc.


September 2016
to support development of a Group B streptococcus (GBS) vaccine for developing country access
$17,252,854
68
Pneumonia, Research and Learning Opportunities
GLOBAL|AFRICA|EUROPE|NORTH AMERICA
Global Health
New York, New York
http://www.pfizer.com/

Visit Our Blog